Exploring the mechanisms of Semaphorin/Plexin-mediated synapse formation in the intact hippocampus
探索完整海马中 Semaphorin/Plexin 介导的突触形成机制
基本信息
- 批准号:10373966
- 负责人:
- 金额:$ 3.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-03-16 至 2023-03-15
- 项目状态:已结题
- 来源:
- 关键词:AdultAffinityAlzheimer&aposs DiseaseAttentionBiological AssayBrainCD100 antigenCell CommunicationCell physiologyCellsChimera organismClinicalCognition DisordersComplexCytoskeletal ModelingDataDevelopmentDown SyndromeERBB2 geneEphrinsEpilepsyExcitatory SynapseExhibitsExtracellular DomainFamilyGenesGlutamatesHeterodimerizationHippocampus (Brain)HomoImaging technologyInhibitory SynapseIon Channel GatingKnock-outKnockout MiceLigandsLinkMediatingMental disordersModelingMolecularMolecular ConformationMusNervous system structureNeuraxisNeurodegenerative DisordersNeurogliaNeurotransmittersPathway interactionsPharmacologyPlayProcessPropertyProtein FamilyProteinsRNA InterferenceReceptor Protein-Tyrosine KinasesRecombinantsResearchRodentRoleSEMA3F geneScaffolding ProteinSeizuresSemaphorinsSignal PathwaySignal TransductionSliceSpecific qualifier valueSynapsesSynaptic VesiclesTestingTimeTo specifyTransgenic MiceTransmembrane DomainWorkautism spectrum disorderaxon guidancecell typedensitydevelopmental neurobiologyexcitatory neuronexperimental studyforward geneticsgamma-Aminobutyric Acidgene discoverygenetic manipulationgenome-widehigh resolution imagingin vivoinhibitorinhibitory neuronknock-downmutantnervous system developmentnoveloverexpressionplexinpostsynapticpostsynaptic neuronspresynapticreceptorresilienceresponsereverse geneticssynaptic functionsynaptogenesistool
项目摘要
Project Summary:
In the mammalian central nervous system, two main types of synapses – glutamatergic and GABAergic – play
opposing roles in exciting or inhibiting the postsynaptic cell. While it is critical that upon cell-cell contact, new
synapses form the correct postsynaptic specialization (excitatory or inhibitory), the molecular pathways
specifying this identity remain a fundamental mystery in developmental neurobiology. This process is
presumably regulated by trans-synaptic ligand/receptor partners that belong to protein families (e.g.
Neuroligins/Neurexins, Ephrins/Ephs, Semaphorins/Plexins) which have been demonstrated to regulate both
excitatory and inhibitory synapse formation.
Semaphorins (Semas) and Plexins are families of widely expressed and functionally versatile transmembrane or
secreted ligands and their transmembrane receptors that first gained attention for their roles in axon guidance
during nervous system development. Class 4 Semas and Plexin-B receptors are expressed in mammalian
hippocampus (in excitatory and inhibitory neurons and in glia) and promote synapse formation both during
development and in adulthood.
Our previous studies revealed Sema4D to be one of few molecules having synaptogenic function restricted to
inhibitory synapses; the extracellular domain of Sema4D induces inhibitory synapse formation on a rapid
timescale (~30 mins) through the Plexin-B1 receptor. Additionally, Sema4A promotes formation of both
inhibitory and excitatory synapses in hippocampus via the Plexin-B1 or Plexin-B2 receptors, respectively. The
ability to rapidly drive synapse formation by application of Sema4A or Sema4D, as well as the observations that
these Semas regulate inhibitory and excitatory synapse formation in unique ways requiring different Plexin-B
receptors, are central to our proposed strategy to identify the distinct signaling conformations that
instruct synapse identity (excitatory or inhibitory) downstream of Plexin-B receptor
engagement. Further, we previously showed that Sema4D protein application increases
resilience to seizure in adult mice in vivo, a finding that supports the potential clinical impact of
this work.
The proposed research uses a combination of transgenic mice, organotypic hippocampal slice culture, gene
knockdown, and expression of mutant forms of Plexin-B receptors to examine the divergent roles of 1) unique
Plexin-B signaling domains, 2) a novel mechanism gating Plexin-B1 signaling in cis, and 3) contributions from
Plexin-B coreceptors, in excitatory and inhibitory synapse formation promoted by class 4 semaphorins.
项目摘要:
在哺乳动物中心神经系统中,两种主要突触类型 - 谷氨酸和加巴能
在令人兴奋或抑制突触后细胞中的角色。
突触形成了正确的突触后专业化(兴奋或抑制),即分子途径
指定这种身份仍然是发展神经生物学的基本谜团
可以由跨突触的配体/受体定制,与蛋白质家族相关的伙伴(例如,
神经素/神经毒素,晶状体/ephs,词素/丛蛋白)已被证明可以调节这两者
精确和抑制性突触形成。
信号蛋白(SEMA)和丛蛋白是广泛表达且功能多功能的跨膜或
分泌的配体及其跨膜受体表明,对轴突指导中角色的门控注意
在神经系统的发展过程中。
海马(在兴奋性和吸入性神经元中以及在神经胶质中)并促进突触形成
发展和成年。
我们以前的研究表明,SEMA4D是少数具有突触功能的分子之一
抑制突触;
时间尺度(〜30分钟)通过plexin-b1受体。
通过plexin-b1或plexin-b2接受的抑制性和兴奋性突触
能够通过SEMA4A或SEMA4D快速驱动突触形成,以及观察
这些SEMAS以独特的方式调节抑制性和兴奋性突触形成方式,方式需要Plexin-B
受体,是我们支撑策略的核心,以确定不同的信号传导构象
指导Plexin-B受体下游的突触身份(兴奋性或入侵)
参与。
体内成年小鼠癫痫发作的弹性,这一发现支持了潜在的临床影响
这项工作。
支撑研究结合了转基因小鼠,器官型海马切片培养,基因。
敲低和丛集受体突变形式的表达,以检查1)独特的作用。
plexin-b信号域,2)一种新型的机制门控在顺式中的机制,以及3)
PLEXIN-B核心,在4类信号素促进的兴奋性和吸入性突触形成中。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Susannah Adel其他文献
Susannah Adel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
面向免疫疗法标志物识别的基于多特征融合的肽与MHC亲和力预测研究
- 批准号:62302277
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
面向多场景应用的药物-靶标结合亲和力预测研究
- 批准号:62371403
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Designing novel therapeutics for Alzheimer’s disease using structural studies of tau
利用 tau 蛋白结构研究设计治疗阿尔茨海默病的新疗法
- 批准号:
10678341 - 财政年份:2023
- 资助金额:
$ 3.54万 - 项目类别:
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
- 批准号:
10660332 - 财政年份:2023
- 资助金额:
$ 3.54万 - 项目类别:
Understanding how social interactions influence reward-seeking behaviors: Developmental mechanisms
了解社交互动如何影响寻求奖励的行为:发展机制
- 批准号:
10716898 - 财政年份:2023
- 资助金额:
$ 3.54万 - 项目类别:
Dopaminergic mechanisms of resilience to Alzheimer's disease neuropathology
阿尔茨海默病神经病理学恢复的多巴胺能机制
- 批准号:
10809199 - 财政年份:2023
- 资助金额:
$ 3.54万 - 项目类别:
Identifying the Mechanisms and Localization of Activity-Dependent CaMKII Synthesis
确定活性依赖性 CaMKII 合成的机制和定位
- 批准号:
10750472 - 财政年份:2023
- 资助金额:
$ 3.54万 - 项目类别: